J Leukoc Biol 2005, 78: 412–425 CrossRefPubMed 13 Cruise MW, Luk

J Leukoc Biol 2005, 78: 412–425.CrossRefPubMed 13. Cruise MW, Lukens JR, Nguyen AP, Lassen MG, Waggoner SN, Hahn YS: Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. J Immunol 2006, 176: 6235–6244.PubMed 14. Watanabe Y, Morita M, Akaike T: Concanavalin

A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996, 24: 702–710.CrossRefPubMed 15. Kusters S, Gantner F, Kunstle G, Tiegs G: Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. buy Tozasertib Gastroenterology 1996, 111: 462–471.CrossRefPubMed 16. Wolf D, Hallmann R, Sass G, Sixt M, Kusters S, Fregien B, Trautwein C, Tiegs G: TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1–relevance for concanavalin A-induced hepatitis. J Immunol 2001, 166: 1300–1307.PubMed 17. Naas T, Ghorbani M, varez-Maya I, Lapner M, Kothary R, De RY, Gomes S, Babiuk L, Milciclib Giulivi A, Soare C, Azizi A, Diaz-Mitoma F: Characterization see more of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 2005, 86: 2185–2196.CrossRefPubMed 18. Ghorbani M, Nass T, Azizi A, Soare C, Aucoin S, Giulivi A, Anderson DE, Diaz-Mitoma F: Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C

immunizations of BALB/c mice. Viral Immunol 2005, 18: 637–648.CrossRefPubMed 19. Sprent J, Surh CD: T cell memory. Annu Rev Immunol 2002, 20: 551–579.CrossRefPubMed 20. Bowen DG, Walker CM: Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005, 436: 946–952.CrossRefPubMed 21. Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999, 30: 595–601.CrossRefPubMed 22. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M: Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing

oxyclozanide mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997, 158: 5283–5291.PubMed 23. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994, 19: 1354–1359.CrossRefPubMed 24. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T: Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994, 204: 468–474.CrossRefPubMed 25. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, Fuke I, Okayama H, Kamada T: Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992, 16: 306–311.CrossRefPubMed 26.

Comments are closed.